Article
Bridget Rasmusson
How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes
Summary
My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success.
In this episode:
- How interviews are being conducted during this time
- Considering the travel bans and limited access, what other activities should MSLs be focusing on during the pandemic?
- Skills mandatory for MSLs during and after the crisis to find success
- How has COVID 19 affected the hiring landscape and what is expected to happen in the upcoming months/year
- How will HCP expectations change as a result of Covid
- How an MSL can meet or exceed expectations during the pandemic
- How does Paul expect Pharma to change practices as a result of Covid-19
- The advice Paul can give to MSLs to help aid in their success
Paul Ward, Oncology MSLs, AstraZeneca, MSL Society, Covid-19 impact on MSLs
Related Topics
You May Also Like
Bridget Rasmusson
Podcast
MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Podcast
MSL Talk: Tom Caravela, Andrew Fariello
How Information is Consumed
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy